MedDataX Logo

ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

NCT ID: NCT01388166

Last Updated: 2014-12-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1253 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-09-30

Study Completion Date

2013-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this observational study is to collect and evaluate data on medication adherence of patients on maintenance COPD therapy with long-acting anticholinergic (e.g. Spiriva® delivered by HandiHaler® or Respimat®) using the MMAS-8 questionnaire.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Purpose:

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with COPD

Education

Intervention Type PROCEDURE

Education

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Education

Education

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and female ambulatory outpatients being seen in a participating physicians office for routine care,
* Patients with a clinical diagnosis of COPD and already being treated with the maintenance therapy with long-acting anticholinergic (Tiotropium (Spiriva® HandiHaler® or Respimat®) at least 1 month and within product label
* Patient fluent in language of questionnaire and having the cognitive and functional abilities required to fill in the questionnaire alone

Exclusion Criteria

* Uncooperative patients as judged by the physician
* Patients with any conditions excluded as per Country specific package insert
* Patients currently enrolled in any clinical trial which requires a change in medication for their respiratory problems.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pfizer

INDUSTRY

Sponsor Role collaborator

Boehringer Ingelheim

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Boehringer Ingelheim

Role: STUDY_CHAIR

Boehringer Ingelheim

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Boehringer Ingelheim Investigational Site 58

Baja, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 85

Békéscsaba, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 61

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 62

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 63

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 66

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 67

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 68

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 89

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 90

Budapest, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 55

Cegléd, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 51

Debrecen, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 64

Dunakeszi, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 77

Dunaújváros, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 56

Edelény, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 78

Esztergom, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 86

Érd, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 60

Gyöngyös, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 52

Hajdúnánás, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 81

Kaposvár, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 54

Kecskemét, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 59

Kistokaj, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 71

Komárom, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 74

Komló, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 65

Mátraháza, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 72

Mosonmagyaróvár, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 83

Nyírbátor, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 53

Nyíregyháza, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 88

Nyíregyháza, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 73

Pécs, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 87

Szeged, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 84

Szentes, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 69

Szigetszentmiklós, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 82

Szombathely, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 76

Tapolca, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 79

Tatabánya, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 57

Tiszaújváros, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 70

Törökszentmiklós, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 75

Várpalota, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 80

Zalaegerszeg, , Hungary

Site Status

Boehringer Ingelheim Investigational Site 29

Banská Bystrica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 41

Bardejov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 42

Bardejov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 32

Bojnice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 1

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 9

Bratislava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 45

Čadca, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 28

Galanta, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 17

Gelnica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 26

Hurbanovo, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 12

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 13

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 14

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 15

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 16

Košice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 25

Levice, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 33

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 35

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 36

Lučenec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 44

Martin, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 38

Michalovce, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 4

Myjava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 22

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 23

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 24

Nitra, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 30

Nová Bana, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 48

Nové Mesto N. Váhom, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 19

Nové Zámky, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 20

Nové Zámky, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 21

Nové Zámky, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 5

Piešťany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 47

Povazská Bystrica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 39

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 40

Prešov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 31

Prievidza, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 11

Rimavská Sobota, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 34

Rimavská Sobota, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 10

Rožňava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 2

Senec, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 3

Senica, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 18

Spisská Nová Ves, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 37

Stropkov, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 27

Topoľčany, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 6

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 7

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 8

Trnava, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 46

Trstená, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 43

Žilina, , Slovakia

Site Status

Boehringer Ingelheim Investigational Site 49

Golnik, , Slovenia

Site Status

Boehringer Ingelheim Investigational Site 50

Maribor-Pohorje, , Slovenia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Hungary Slovakia Slovenia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

205.483

Identifier Type: -

Identifier Source: org_study_id